Orrick advised Catalyst Biosciences, Inc. on the deal. South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc. announced its acquisition of the F351 program, a next-generation fibrosis drug,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised HIBio on the deal while Orrick represented MorphoSys. HIBio announced its equity participation agreement and license agreements with MorphoSys AG (FSE: MOR; NASDAQ: MOR)....
You must be a Standard 1 Year member to access this content.
Orrick Herrington & Sutcliffe advised True Wind Capital on the deal. True Wind Capital announced its investment in W Energy Software, a provider of cloud-based accounting and...
You must be a Standard 1 Year member to access this content.
Orrick Herrington & Sutcliffe advised Sizewise on the deal. Sizewise Rentals announced its definitive agreement to be acquired by Agiliti, a service provider to the U.S. healthcare...
You must be a Standard 1 Year member to access this content.
Orrick Herrington & Sutcliffe LLP advised Reigning Champs on the deal. Reigning Champs, a portfolio company of the Raine Group, announced its $200 million sale to Endeavor...
You must be a Standard 1 Year member to access this content.
Orrick Herrington & Sutcliffe LLP advised Pitney Bowes on the deal. Oon & Bazul acted for Grid Dynamics Holdings Inc. Pitney Bowes, a NYSE-listed company, announced its...
You must be a Standard 1 Year member to access this content.
